Treat-and-extend comparable to monthly injections in AMD
The TREND study recruited 650 treatment-naive patients with active choroidal neovascularization secondary to AMD in 90 centers across 18 countries, randomly assigned to treat-and-extend or monthly ranibizumab 0.5 mg. According to the authors, "the [treat-and-extend] regimen considers these vary...
Gespeichert in:
Veröffentlicht in: | Primary Care Optometry News 2017-10, Vol.22 (10), p.6-6 |
---|---|
1. Verfasser: | |
Format: | Artikel |
Sprache: | eng |
Schlagworte: | |
Online-Zugang: | Volltext |
Tags: |
Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
|
Zusammenfassung: | The TREND study recruited 650 treatment-naive patients with active choroidal neovascularization secondary to AMD in 90 centers across 18 countries, randomly assigned to treat-and-extend or monthly ranibizumab 0.5 mg. According to the authors, "the [treat-and-extend] regimen considers these varying patient requirements, thus allowing for a tailored follow-up schedule" - by Michela Cimberle РИМ Reference: Silva R, et al. |
---|---|
ISSN: | 1081-6437 |